Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma - Contacts and Locations

Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

This study is currently recruiting participants.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00288067

Locations


United States, Washington
	Fred Hutchinson Cancer Research Center	Recruiting
	Seattle, Washington, United States, 98109-1024
	Contact: John Pagel, MD, PhD 206-667-1868
	Seattle Cancer Care Alliance	Recruiting
	Seattle, Washington, United States, 98109-1023
	Contact: Clinical Trials Office - Seattle Cancer Care Alliance 800-804-8824

Sponsors and Collaborators

University of Washington

National Cancer Institute (NCI)

Investigators


Study Chair:	Ajay K. Gopal, MD	Seattle Cancer Care Alliance

Investigator:	John Pagel, MD, PhD	Fred Hutchinson Cancer Research Center